Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery
Molecular Pharmaceutics · 06.04.2026 · 23 (4) · 2792-2804
DOI: 10.1021/acs.molpharmaceut.5c01966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.03.2026. Verfasst von Do Hyun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Laboratory Science, Yonsei University, Wonju 26493, South Korea. Hauptthemen laut MEDLINE: Doxorubicin, Aptamers, Nucleotide, Nanoparticles, Erythrocyte Membrane. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biomedical Laboratory Science, Yonsei University, Wonju 26493, South Korea.
- The DABOM Inc., Seoul 03722, South Korea.
- School of Medicine, Trinity Medical Sciences University, Warner Robins, Georgia 31093, United States.
- Department of Surgery, Yonsei University College of Medicine, Seoul 03722, South Korea.
- Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, United States.
ORCID-Profile: Kangchan Choi, Moon Jung Choi
Zitieren
APA
Lee, D. H., Choi, K., Lee, J. W., Kim, M. W., Park, Y. S., & Choi, M. J. (2026). Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery. Molecular Pharmaceutics, 23(4), 2792-2804. https://doi.org/10.1021/acs.molpharmaceut.5c01966
Vancouver
Lee DH, Choi K, Lee JW, Kim MW, Park YS, Choi MJ. Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery. Molecular Pharmaceutics. 2026;23(4):2792-2804. doi:10.1021/acs.molpharmaceut.5c01966
BibTeX
@article{Lee2026,
author = {Lee, Do Hyun and Choi, Kangchan and Lee, Ji Won and Kim, Min Woo and Park, Yong Serk and Choi, Moon Jung},
title = {Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {4},
pages = {2792--2804},
doi = {10.1021/acs.molpharmaceut.5c01966}
}
EUVIMED